Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001232711 | SCV001405279 | pathogenic | LAMA2-related muscular dystrophy | 2024-03-28 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu2460Serfs*2) in the LAMA2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LAMA2 are known to be pathogenic (PMID: 18700894, 32904964). This variant is present in population databases (rs749566145, gnomAD 0.06%). This premature translational stop signal has been observed in individual(s) with congenital muscular dystrophy (PMID: 11938437, 21520333). This variant is also known as 7426insT. ClinVar contains an entry for this variant (Variation ID: 959370). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV002497794 | SCV002808046 | likely pathogenic | Merosin deficient congenital muscular dystrophy; Muscular dystrophy, limb-girdle, autosomal recessive 23 | 2022-01-05 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003469420 | SCV004190419 | likely pathogenic | Merosin deficient congenital muscular dystrophy | 2024-03-14 | criteria provided, single submitter | clinical testing |